1. Home
  2. WST vs CYBR Comparison

WST vs CYBR Comparison

Compare WST & CYBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • CYBR
  • Stock Information
  • Founded
  • WST 1923
  • CYBR 1999
  • Country
  • WST United States
  • CYBR Israel
  • Employees
  • WST N/A
  • CYBR N/A
  • Industry
  • WST Medical/Dental Instruments
  • CYBR Computer Software: Prepackaged Software
  • Sector
  • WST Health Care
  • CYBR Technology
  • Exchange
  • WST Nasdaq
  • CYBR Nasdaq
  • Market Cap
  • WST 18.9B
  • CYBR 20.8B
  • IPO Year
  • WST N/A
  • CYBR 2014
  • Fundamental
  • Price
  • WST $246.18
  • CYBR $423.85
  • Analyst Decision
  • WST Buy
  • CYBR Buy
  • Analyst Count
  • WST 7
  • CYBR 34
  • Target Price
  • WST $332.50
  • CYBR $434.93
  • AVG Volume (30 Days)
  • WST 841.4K
  • CYBR 2.6M
  • Earning Date
  • WST 07-24-2025
  • CYBR 07-30-2025
  • Dividend Yield
  • WST 0.36%
  • CYBR N/A
  • EPS Growth
  • WST N/A
  • CYBR N/A
  • EPS
  • WST 6.68
  • CYBR N/A
  • Revenue
  • WST $2,960,200,000.00
  • CYBR $1,200,117,000.00
  • Revenue This Year
  • WST $5.70
  • CYBR $34.80
  • Revenue Next Year
  • WST $6.05
  • CYBR $19.64
  • P/E Ratio
  • WST $36.83
  • CYBR N/A
  • Revenue Growth
  • WST 2.90
  • CYBR 39.45
  • 52 Week Low
  • WST $187.43
  • CYBR $254.43
  • 52 Week High
  • WST $352.33
  • CYBR $452.00
  • Technical
  • Relative Strength Index (RSI)
  • WST 57.91
  • CYBR 59.85
  • Support Level
  • WST $237.18
  • CYBR $414.41
  • Resistance Level
  • WST $244.36
  • CYBR $429.31
  • Average True Range (ATR)
  • WST 5.82
  • CYBR 17.15
  • MACD
  • WST -0.41
  • CYBR 1.28
  • Stochastic Oscillator
  • WST 51.10
  • CYBR 62.21

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About CYBR CyberArk Software Ltd.

CyberArk is a cybersecurity vendor focused on the identity market. The company's core privileged access management offering is a market leader in that subsegment, with more than half of the Fortune 500 as CyberArk customers. The identity security vendor was founded in 1999 and has around 9,000 customers across various industries. While CyberArk historically sold its security solutions primarily via on-premises licenses, over the past few years it has transitioned to a subscription recurring-revenue model.

Share on Social Networks: